Products are for professional/laboratory use only. We are happy to announce the launch of the new VirClia® monotest to detect and quantify IgG antibodies against SARS-CoV-2 Spike in human serum or plasma, with strong correlation to neutralizing antibodies.
Products are for professional/laboratory use only. Over 30 million people are at risk of invasive aspergillosis each year due to use of corticosteroids, chemotherapy or other immunosuppressive agents, and over 300,000 patients develop it annually.1
The VirClia® Lotus is a new and fully automated chemiluminescence instrument for infectious disease serology, utilising the unique Vircell Monotest strip.
A fully automated solution for Hepatitis E serology with the VirClia® instruments will allow obtaining results on the same day the sample is collected and avoid batch testing.
The first Abacus dx Infectious Disease breakfast seminar was held on the 15th October on the Gold Coast. The meeting focused on novel automated solutions for infectious serology testing.
We would like to share with you a recent publication on the benefits of the Vircell VirClia analyser written by Jamie Laughlin, Head of Operations at the South West London Pathology (SWLP), St George’s University Hospitals NHS Foundation Trust, UK.
The Virclia® system it is a small automated platform that will serve as the ideal complementary system for those esoteric and low volume tests. To improve turn around time and the efficiency in your laboratory.
Abacus dx is pleased to announce the release of the Vircell RRV ELISA and also the fully automated VirClia® RRV IgG and IgM Monotest into the Australian market.
Invasive Candidiasis (IC) plays an important role as a severe infection hospital patients in intensive care, post-surgical and immunocompromised patients.